| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | 5-FU | CTRPv2 | pan-cancer | AAC | -0.0036 | 0.9 |
| mRNA | GDC-0941 | gCSI | pan-cancer | AAC | -0.0061 | 0.9 |
| mRNA | Sunitinib | GDSC1000 | pan-cancer | AAC | 0.0054 | 0.9 |
| mRNA | NG-25 | GDSC1000 | pan-cancer | AAC | -0.0031 | 0.9 |
| mRNA | Nutlin-3 | CTRPv2 | pan-cancer | AAC | 0.0033 | 0.9 |
| mRNA | SNS-032 | CTRPv2 | pan-cancer | AAC | -0.0035 | 0.9 |
| mRNA | BRD-K71781559 | CTRPv2 | pan-cancer | AAC | 0.0037 | 0.9 |
| mRNA | masitinib | CTRPv2 | pan-cancer | AAC | 0.0032 | 0.9 |
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | 0.0029 | 0.9 |
| mRNA | carboplatin:UNC0638 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.003 | 0.9 |